锚定新质生产力等方向 月内险资调研A股公司近600次

Core Insights - The trend of insurance capital (险资) research in A-shares has shown a significant decline in frequency, with 2023, 2024, and 2025 projected to have 30,300, 22,300, and 18,400 instances respectively, indicating a shift towards quality over quantity in investment strategies [1][2] Group 1: Research Frequency and Focus - As of January 28, 2023, insurance institutions conducted 592 research instances on A-share companies, with a notable increase in focus on the Sci-Tech Innovation Board and the Growth Enterprise Market [1] - Among the 592 research instances, insurance companies accounted for 281, while insurance asset management companies conducted 311, with leading firms being Taiping Pension, China People's Pension, and Changjiang Pension for insurance companies, and Taikang Asset Management, Huatai Asset Management, and Dajia Asset Management for asset management companies [1] - The focus of insurance capital has shifted towards high-end manufacturing and new productive forces, with significant attention on sectors such as industrial machinery, electronic equipment, and healthcare devices [3] Group 2: Investment Strategy and Trends - The decline in research frequency is attributed to a strategic shift from broad coverage to in-depth analysis, leveraging big data and internal research systems to focus on core targets [2] - The improvement in A-share information disclosure quality and institutional deepening has enhanced the efficiency of fundamental assessments, leading to a more concentrated approach in research activities [2] - Insurance capital is increasingly focusing on high-dividend assets and long-term allocations, moving away from short-term trading strategies, which reflects a maturation of professional institutions [2] Group 3: Future Outlook - The preference of insurance capital for research is driven by a dual focus on national strategy and liability matching, necessitating long-term growth assets [4] - It is anticipated that by 2026, the frequency of insurance capital research will stabilize or slightly increase, with a higher emphasis on quality and alignment with policy-supported sectors [4] - As confidence in the A-share market grows, insurance capital is expected to play a more prominent role as "patient capital," concentrating research on companies with core technologies and strong governance [4]